Alles MS, Hautfast JG, Nagengast FM, Hartemink R, Van Laere KM & Jansen FM (1996) Fate of fructo-oligosaccharides in the human intestine. British Journal of Nutrition 76, 211–221.
Amann RI, Ludwig W & Schleifer K-H (1995) Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbial Reviews 59, 143–169.
Andrieux C, Lory S, Dufour-Lescoat CD, de Baynast R & Szylit O (1991) Physiological effects of inulin in germ-free rats and in heteroxenic rats inoculated with a human flora. Food Hydrocolloids 5, 49–56.
Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C & Flint HJ (2000) Phylogenetic relationship of butyrate-producing bacteria from the human gut. Applied and Environmental Microbiology 66, 1654–1661.
Beimfohr C, Krause A, Amann RI, Ludwig W & Schleifer K-H (1993) In situ identification of lactococci, enterococci and streptococci. Systematic and Applied Microbiology 16, 450–456.
Bouhnik Y, Flourie B, Andrieux C, Bisetti N, Briet F & Rambaud J-C (1996) Effects of Bifidobacterium sp. fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans. European Journal of Clinical Nutrition 50, 269–273.
Bouhnik Y, Vahedi K, Achour L, Attar A, Salfati J, Pochart P, Marteau P, Flourie B, Bornet F & Rambaud J-C (1999) Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. Journal of Nutrition 129, 113–116.
Buddington RK, Williams CH, Chen SC & Whitherly SA (1996) Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. American Journal of Clinical Nutrition 63, 709–716.
Burke A, Lichtenstein GR & Rombeau JL (1997) Nutrition and ulcerative colitis. Baillieres Clinical Gastroenterology 11, 153–174.
Campbell JM, Fahey GC & Bryan WW (1997) Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. Journal of Nutrition 127, 130–136.
Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez-Garayzabal J, Garcia P, Cai J, Hippe H & Farrow JAE (1994) The phylogeny of the genus Clostridium: proposal of five genera and eleven new species combinations. International Journal of Systematic Bacteriology 44, 812–826.
Cummings JH (1981) Short chain fatty acids in the human colon. Gut 22, 763–779.
Cummings JH, Beatty ER, Kingman SM, Bingham SA & Englyst HN (1996) Digestion and physiological properties of resistant starch in the human large bowel. British Journal of Nutrition 75, 733–747.
Cummings JH & Macfarlane GT (1991) The control and consequences of bacteria fermentation in the human colon. Journal of Applied Microbiology 70, 443–459.
Cummings JH & Macfarlane GT (1997) Role of intestinal bacteria in nutrient metabolism. Clinical Nutrition 16, 3–11.
Djouzi Z & Andrieux C (1997) Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora. British Journal of Nutrition 78, 313–324.
Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Shut F & Welling GW (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Applied and Environmental Microbiology 64, 3336–3345.
Gibson GR (1999) Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. Journal of Nutrition 129, 1438S–1441S.
Gibson GR, Beatty EB, Wang X & Cummings JH (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975–982.
Gibson GR & Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 125, 1401–1412.
Gibson GR & Wang X (1994) Regulatory effects of bifidobacteria on the growth of other colonic bacteria. Journal of Applied Bacteriology 74, 667–674.
Hague A, Butt AJ & Paraskeva A (1996) The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proceedings of the Nutrition Society 55, 937–943.
Harmsen HJM, Elfferich P, Shut F & Welling G.W. (1999) A 16SrRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microbial Ecology in Health and Disease 11, 3–12.
Hentges DJ (1967) Influence of pH on the inhibitory activity of formic and acetic acids for Shigella. Journal of Bacteriology 93, 2029–2030.
Hidaka H, Eida T, Takizawa T, Tokunaga T & Tashiro Y (1986) Effects of fructooligosaccharides on intestinal flora and human health. Bifidobacteria Microflora 5, 37–50.
Jacobasch G, Schmiedl D, Kruschewski M & Schmehl K (1999) Dietary resistant starch and chronic inflammatory bowel diseases. International Journal of Colorectal Diseases 14, 201–211.
Kleessen B, Noack J & Blaut M (1999) Distribution of viable and non-viable bacteria in the gastrointestinal tract of gnotobiotic and conventional rats. Microbiology Ecology in Health and Disease 11, 218–225.
Kleessen B, Sykura B, Zunft H-J & Blaut M (1997) Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. American Journal of Clinical Nutrition 65, 1397–1402.
Kruse H-P, Kleessen B & Blaut M (1999) Effects of inulin on faecal bifidobacteria in human subjects. British Journal of Nutrition 82, 375–382.
Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MHF & Welling GW (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16 S rRNA-targeted probes and its application in fecal samples. Applied and Environmental Microbiology 61, 3069–3075.
Le Blay G, Michel C, Blottiere HM & Cherbut C (1999) Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats. Journal of Nutrition 129, 2231–2235.
Manz W, Amann R, Ludwig W, Vancanneyt M & Schleifer K-H (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142, 1097–1106.
Manz W, Szewzyk U, Eriksson P, Amann R, Schleifer K-H & Stenström TA (1993) In situ identification of bacteria in drinking water and adjoining biofilms by hybridization with 16S and 23S rRNA-directed fluorescent oligonucleotide probes. Applied and Environmental Microbiology 59, 2293–2298.
Mallet AK, Bearne CA, Roland IR, Farthing MJG, Cole CB & Fuller R (1987) The use of rats associated with a human faecal flora as a model for studying the effect of diet on the human gut microflora. Journal of Applied Bacteriology 63, 39–45.
Massimino SP, McBurney MI, Field CJ, Thomson ABR, Keelan M, Hayek MG & Sunvold GD (1998) Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. Journal of Nutrition 128, 1786–1793.
Menne E, Guggenbuhl N & Roberfroid M (2000) Fn-type chicory inulin hydrolysate has a prebiotic effect in humans. Journal of Nutrition 130, 1197–1199.
Morita T, Kasaoka S, Hase K & Kiriyama S (1999) Psyllium shifts the fermentation site of high-amylose cornstarch toward the distal colon and increases fecal butyrate concentration in rats. Journal of Nutrition 129, 2081–2087.
Poulsen LK, Licht TR, Rang C, Krogfelt KA & Molin S (1995) Physiological state of E. coli BJ4 growing in the large intestines of streptomycin-treated mice. Journal of Bacteriology 177, 5840–5845.
Prosky L, Asp N-G, Schweizer TF, De Vries J & Furda I (1988) Determination of insoluble, soluble, and total dietary fiber in foods and food products: interlaboratory study. Journal of the Association Analytical Chemists 71, 1017–1023.
Rao AV (1999) Dose-response effects of inulin and oligofructose on intestinal bifidogenesis effects. Journal of Nutrition 129, 1442S–1445S.
Reddy SR, Hamid R & Rao CV (1997) Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18, 1371–1374.
Roberfroid MB (1997) Health benefits of non-digestible oligosaccharides. Advances in Experimental Medical Biology 427, 211–219.
Roberfroid MB (2000) Prebiotics and probiotics: are they functional foods? American Journal of Clinical Nutrition 71 Suppl., 1682S–1687S.
Roberfroid MB & Delzenne NM (1998) Dietary fructans. Annual Review of Nutrition 18, 117–143.
Roberfroid MB, Van Loo JA & Gibson GR (1998) The bifidogenic nature of chicory inulin and its hydrolysis products. Journal of Nutrition 128, 11–19.
Roediger WEW (1995) The place of short-chain fatty acids in colonocyte metabolism in health and ulcerative colitis: the impaired colonocyte barrier. In Physiological and Clinical Aspects of Short-Chain Fatty Acids, pp. 337–351 [Cummings JH, Rombeau JL and Sakata T, editors]. Cambridge: University Press.
Rumney CJ & Rowland IR (1992) In vivo and in vitro models of the human colonic flora. Critical Reviews in Food Science and Nutrition 31, 299–331.
Sakata T (1987) Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects on fermentable fibre, gut microbes and luminal trophic factors. British Journal of Nutrition 58, 95–103.
Sghir A, Chow JM & Mackie RI (1998) Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharide as selective substrate. Journal of Applied Microbiology 85, 769–777.
Simpson EJ, Chapman MAS, Dawson J, Berry D, Macdonald A & Cole A (2000) In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut 46, 73–77.
Smith JG, Yokoyama WH & German JB (1998) Butyric acid from the diet: Actions at the level of gene expression. Critical Reviews in Food Science and Nutrition 38, 259–297.
Tappenden KA, Drozdowski LA, Thomson ABR & McBurney MI (1998) Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. American Journal of Clinical Nutrition 68, 118–125.
Treem WR, Ahsan N, Shoup M & Hyams JS (1994) Fecal short-chain fatty acids in children with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition 18, 159–164.
Van Loo J, Coussement P, De Leenheer L, Hoebregs H & Smits G (1995) On the presence of inulin and oligofructose as natural ingredients in the Western diet. Critical Reviews in Food Science and Nutrition 35, 525–552.
Van Loo J, Cummings J, Delzenne N, Englyst H, Franck A, Hopkins M, Kok N, Macfarlane G, Newton D, Quigley M, Roberfroid M, Van Vliet T & Van den Heuvel E (1999) Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). British Journal of Nutrition 81, 121–132.
Velazquez OC, Lederer HM & Rombeau JL (1996) Butyrate and the colonocyte. Implications for neoplasia. Digestive Disease and Science 41, 729–739.
Wang X & Gibson GR (1993) Effect of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. Journal of Applied Bacteriology 75, 373–380.
Weaver GA, Krause JA, Miller TL & Wolin MJ (1988) Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer. Gut 29, 1539–1543.
Welling GW, Elfferich P, Raangs GC, Wildeboer-Veloo ACM, Jansen GJ & Degener JE (1997) 16S rRNA-targeted oligonucleotide probes for monitoring of intestinal tract bacteria. Scandinavian Journal of Gastroenterology 32 Suppl. 222, 17–19.
Wilcoxon F & Wilcox RA (1964) Some Rapid Approximate Statistical Procedures, New York, NY: Lederle Laboratories.
Zar JH (1984) Biostatistical Analysis, 2nd ed, New York, NY: Prentice-Hall.